{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:45:08Z","timestamp":1791409508855,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1124\/jpet.112.200832","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T08:15:50Z","timestamp":1354954550000},"page":"378-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"344","author":[{"given":"Stephen E.","family":"Spurgeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke B.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Druker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"DeGuzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Hollenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Loriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.200832_bib1","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/onc.2009.179","article-title":"The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression","volume":"28","author":"Baudot","year":"2009","journal-title":"Oncogene"},{"key":"10.1124\/jpet.112.200832_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"10.1124\/jpet.112.200832_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.200832_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semcancer.2010.11.001","article-title":"Where is the biology of CLL leading us?","volume":"20","author":"Caligaris-Cappio","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1124\/jpet.112.200832_bib5","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2006-03-013821","article-title":"Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib6","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","article-title":"SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/378303a0","article-title":"Syk tyrosine kinase required for mouse viability and B-cell development","volume":"378","author":"Cheng","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.112.200832_bib8","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1182\/blood-2011-02-333773","article-title":"SYK inhibition and response prediction in diffuse large B-cell lymphoma","volume":"118","author":"Cheng","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.112.200832_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/jpet.111.188441","article-title":"Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis","volume":"340","author":"Coffey","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.200832_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1124\/jpet.112.200832_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/cbmr.1999.1509","article-title":"CombiTool\u2014a new computer program for analyzing combination experiments with biologically active agents","volume":"32","author":"Dressler","year":"1999","journal-title":"Comput Biomed Res"},{"key":"10.1124\/jpet.112.200832_bib13","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0609.1999.tb01766.x","article-title":"Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin\u2019s lymphoma cell lines","volume":"63","author":"Gabay","year":"1999","journal-title":"Eur J Haematol"},{"key":"10.1124\/jpet.112.200832_bib15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.346","article-title":"Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"23","author":"Gobessi","year":"2009","journal-title":"Leukemia"},{"key":"10.1124\/jpet.112.200832_bib16","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.4049\/jimmunol.176.10.5715","article-title":"Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma","volume":"176","author":"Gururajan","year":"2006","journal-title":"J Immunol"},{"key":"10.1124\/jpet.112.200832_bib17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Hoellenriegel","year":"2012","journal-title":"Leukemia"},{"key":"10.1124\/jpet.112.200832_bib18","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","article-title":"Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells","volume":"108","author":"Irish","year":"2006","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.immunol.23.021704.115606","article-title":"B cell signaling and tumorigenesis","volume":"23","author":"Jumaa","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/jpet.112.200832_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2004.05.014","article-title":"Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer","volume":"117","author":"Kraus","year":"2004","journal-title":"Cell"},{"key":"10.1124\/jpet.112.200832_bib21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V97.4.1050","article-title":"Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)","volume":"97","author":"Kuno","year":"2001","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"key":"10.1124\/jpet.112.200832_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","article-title":"CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability","volume":"117","author":"Lannutti","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib24","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","article-title":"Syk-dependent mTOR activation in follicular lymphoma cells","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.112.200832_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(02)00303-5","article-title":"Syk is required for integrin signaling in neutrophils","volume":"16","author":"M\u00f3csai","year":"2002","journal-title":"Immunity"},{"key":"10.1124\/jpet.112.200832_bib27","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib28","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.139.7.2172","article-title":"Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion","volume":"139","author":"Mountz","year":"1987","journal-title":"J Immunol"},{"key":"10.1124\/jpet.112.200832_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/intimm\/dxs078","article-title":"Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis","volume":"24","author":"Ozaki","year":"2012","journal-title":"Int Immunol"},{"key":"10.1124\/jpet.112.200832_bib30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/ni1202-1129","article-title":"Hydrogen peroxide as second messenger in lymphocyte activation","volume":"3","author":"Reth","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.112.200832_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma","volume":"132","author":"Rinaldi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.112.200832_bib33","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/sj.leu.2404831","article-title":"Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation","volume":"21","author":"Rodr\u00edguez","year":"2007","journal-title":"Leukemia"},{"key":"10.1124\/jpet.112.200832_bib34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.immuni.2005.03.004","article-title":"Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins","volume":"22","author":"Rogers","year":"2005","journal-title":"Immunity"},{"key":"10.1124\/jpet.112.200832_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1097-2765(02)00739-6","article-title":"Amplification of B cell antigen receptor signaling by a Syk\/ITAM positive feedback loop","volume":"10","author":"Rolli","year":"2002","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.112.200832_bib36","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/sj.onc.1209520","article-title":"SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells","volume":"25","author":"Sprangers","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/jpet.112.200832_bib37","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.112.200832_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.200832_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.leukres.2009.11.005","article-title":"Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors","volume":"34","author":"Tavolaro","year":"2010","journal-title":"Leuk Res"},{"key":"10.1124\/jpet.112.200832_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.112.200832_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-5699(99)01574-1","article-title":"Tyrosine kinase SYK: essential functions for immunoreceptor signalling","volume":"21","author":"Turner","year":"2000","journal-title":"Immunol Today"},{"key":"10.1124\/jpet.112.200832_bib42","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1002\/eji.201141502","article-title":"Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo","volume":"41","author":"Wex","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.112.200832_bib43","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1084\/jem.20060967","article-title":"Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells","volume":"203","author":"Wossning","year":"2006","journal-title":"J Exp Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.200832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:18:24Z","timestamp":1739985504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0022356524185035"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.200832","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.200832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}